AEGON Successfully Completes Sale of EUR 842 Million 'SAECURE 9' RMBS Notes

By Aegon N.v., PRNE
Sunday, September 26, 2010

Not for Distribution in the USA

THE HAGUE, The Netherlands, September 27, 2010 - AEGON announces that it has successfully completed the sale of EUR 842
residential mortgage-backed securities* (RMBS) to a broad group of
institutional investors.

These securities were issued under the Dutch SAECURE program** and
consisted of two tranches:

    - EUR 180 million of class A1 notes with an expected weighted average
      life of 1.7 years and priced at par with a coupon of three month
      Euribor plus 0.95 %.

    - EUR 662 million of class A2 notes with an expected weighted average
      life of 5.4 years and priced at par with a coupon of three month
      Euribor plus 1.35 %.

The net proceeds will be used to finance a part of AEGON's existing Dutch
mortgage portfolio.

AEGON is pleased it was able to successfully complete the sale despite
challenging market conditions. SAECURE continues to be regarded as a top tier
program in the Dutch RMBS market. AEGON's proven underwriting criteria and
servicing have led to high quality performance on the company's outstanding
SAECURE transactions.

The securities were placed by a syndicate of banks comprising ING Bank,
J.P. Morgan Securities, Rabobank International and The Royal Bank of

* The securities are rated AAA by Standard & Poor's and Aaa by Moody's
Investor Service

** The SAECURE program is managed by AEGON's subsidiary AEGON
Levensverzekering N.V.


As an international life insurance, pension and investment company based
in The Hague, AEGON has businesses in over twenty markets in the Americas,
Europe and Asia. AEGON companies employ approximately 28,000 people
and have some 40 million customers across the globe.

    Key figures                               Full year
                            Second quarter
    EUR                               2010         2009
    Underlying earnings
    before tax                 522 million  1.2 billion
    New life sales             590 million  2.1 billion
    Gross deposits (excl.
    run-off)                   7.6 billion   28 billion
    Revenue generating
    (end of period)            409 billion  363 billion

Forward-looking statements

The statements contained in this press release that are not historical
facts are forward-looking statements as defined in the US Private Securities
Litigation Reform Act of 1995. The following are words that identify such
forward-looking statements: aim, believe, estimate, target, intend, may,
expect, anticipate, predict, project, counting on, plan, continue, want,
forecast, goal, should, would, is confident, will, and similar expressions as
they relate to our company. These statements are not guarantees of future
performance and involve risks, uncertainties and assumptions that are
difficult to predict. We undertake no obligation to publicly update or revise
any forward-looking statements. Readers are cautioned not to place undue
reliance on these forward-looking statements, which merely reflect company
expectations at the time of writing. Actual results may differ materially
from expectations conveyed in forward-looking statements due to changes
caused by various risks and uncertainties. Such risks and uncertainties
include but are not limited to the following:

    - Changes in general economic conditions, particularly in the United
      States, the Netherlands and the United Kingdom;

    - Changes in the performance of financial markets, including emerging
      markets, such as with regard to:

      - The frequency and severity of defaults by issuers in our fixed income
        investment portfolios; and

      - The effects of corporate bankruptcies and/or accounting restatements
        on the financial markets and the resulting decline in the value of
        equity and debt securities we hold;

    - The frequency and severity of insured loss events;

    - Changes affecting mortality, morbidity and other factors that may
      impact the profitability of our insurance products;

    - Changes affecting interest rate levels and continuing low or rapidly
      changing interest rate levels;

    - Changes affecting currency exchange rates, in particular the EUR/USD
      and EUR/GBP exchange rates;

    - Increasing levels of competition in the United States, the Netherlands,
      the United Kingdom and emerging markets;

    - Changes in laws and regulations, particularly those affecting our
      operations, the products we sell, and the attractiveness of certain
      products to our consumers;

    - Regulatory changes relating to the insurance industry in the
      jurisdictions in which we operate;

    - Acts of God, acts of terrorism, acts of war and pandemics;

    - Changes in the policies of central banks and/or governments;

    - Lowering of one or more of our debt ratings issued by recognized rating
      organizations and the adverse impact such action may have on our
      ability to raise capital and on our liquidity and financial condition;

    - Lowering of one or more of insurer financial strength ratings of our
      insurance subsidiaries and the adverse impact such action may have on
      the premium writings, policy retention, profitability of its insurance

      subsidiaries and liquidity;

    - The effect of the European Union's Solvency II requirements and other
      regulations in other jurisdictions affecting the capital we are
      required to maintain;

    - Litigation or regulatory action that could require us to pay
      significant damages or change the way we do business;

    - Customer responsiveness to both new products and distribution channels;

    - Competitive, legal, regulatory, or tax changes that affect the
      distribution cost of or demand for our products;

    - The impact of acquisitions and divestitures, restructurings, product
      withdrawals and other unusual items, including our ability to integrate
      acquisitions and to obtain the anticipated results and synergies from

    - Our failure to achieve anticipated levels of earnings or operational
      efficiencies as well as other cost saving initiatives; and

    - The impact our adoption of the International Financial Reporting
      Standards may have on our reported financial results and financial

Further details of potential risks and uncertainties affecting the
company are described in the company's filings with Euronext Amsterdam and
the US Securities and Exchange Commission, including the Annual Report on
Form 20-F. These forward-looking statements speak only as of the date of this
document. Except as required by any applicable law or regulation, the company
expressly disclaims any obligation or undertaking to release publicly any
updates or revisions to any forward-looking statements contained herein to
reflect any change in the company's expectations with regard thereto or any
change in events, conditions or circumstances on which any such statement is

    Contact information

    Media relations: Greg Tucker

    Investor relations: Gerbrand Nijman

Contact information: Media relations: Greg Tucker, +31(0)70-344-8956, gcc-ir at; Investor relations: Gerbrand Nijman, +31(0)70-344-8305, ir at

will not be displayed